Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,928 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Healthcare Innovations Institute Inc Coral Springs, Florida, United States
  • Neurology Associates PA Maitland, Florida, United States
  • ALS Center at the University of Miami Miami, Florida, United States
View all 118 locations
View Trial Details
Recruiting

A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

NCT07074886

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Profound Research, LLC Carlsbad, California, United States
  • Advanced Neurology of Colorado, LLC Fort Collins, Colorado, United States
  • Neurology Associates PA Maitland, Florida, United States
  • University of South Florida Tampa, Florida, United States
View all 56 locations
View Trial Details
Recruiting

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06752356

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • USF Health - Morsani Center for Advanced Healthcare Tampa, Florida, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Advanced Neurology Epilepsy and Sleep Center/ANESC Research El Paso, Texas, United States
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

NCT05704361

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Yale University Multiple Sclerosis Center New Haven, Connecticut, United States
  • University of South Florida Tampa, Florida, United States
  • University of Massachusetts Medical School Worcester, Massachusetts, United States
View all 32 locations
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis

NCT07507084

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Kütahya Sağlık Bilimleri Üniversitesi, Sağlıklı Yaşam Fizyoterapi ve Rehabilitasyon Merkezi Kütahya, Merkez, Turkey (Türkiye)
View Trial Details
Recruiting

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

NCT06675864

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Bron, France
View all 18 locations
View Trial Details

Related conditions